Update on global hard and soft regulatory changes affecting biopharma.Focus on EU: Green Deal, Circular Economy, Sustainable Finance, Non-Financial Reporting Directive.Speaker: Olivier Jaeggi, Managing Director, ECO:FACT Request link to Forum Presentation
Regulatory and ESG Policy Outlook for Biopharma Read More »
Roundtable Forum with Lise Kingo.Biopharma sustainability oversight and governance priorities.Speaker: Lise Kingo, Independent Director, Sanofi; former Executive Director, UN Global Compact Request link to Forum Presentation
Business Leadership and Governance in Biopharma Read More »
Connecting Biopharma Sustainability and Long-Term Planning — A collaboration with CECP’s CEO Investor Forum. Initial release of our Executive Report and Practitioner’s Guide for integrating sustainability and long-term planning for biopharma companies. Watch Video
Is Biopharma Future-Proof? ESG and Long-Term Planning Read More »
A direct conversation between Biopharma sustainability leaders and sector investors about metrics for the sector’s highest-priority ESG topics.
Biopharma Investor Workshop #3 Read More »
First look at a new sector initiative focused on collective downstream product stewardship.
Introducing the Sustainable Medicines Partnership Read More »
BSRT Stakeholder Dialog follow-up to discuss connections between the ESG Communications Guidance and EFPIA’s developing Value Framework for social impact.
EFPIA Value Framework Read More »
